Follow
Christian Jekimovs
Christian Jekimovs
PhD Student, Queensland University of Technology
Verified email at qut.edu.au - Homepage
Title
Cited by
Cited by
Year
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint
T Bruno, F De Nicola, S Iezzi, D Lecis, C D'Angelo, M Di Padova, N Corbi, ...
Cancer cell 10 (6), 473-486, 2006
1462006
Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising
C Jekimovs, E Bolderson, A Suraweera, M Adams, KJ O’Byrne, ...
Frontiers in Oncology 4, 86, 2014
1352014
Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals
CR Jekimovs, X Chen, J Arnold, M Gatei, DJ Richard, AB Spurdle, ...
British journal of cancer 92 (4), 784-790, 2005
562005
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
A Suraweera, A Duff, MN Adams, C Jekimovs, PHG Duijf, C Liu, ...
British Journal of Cancer 123 (4), 591-603, 2020
162020
COMMD1, from the repair of DNA double strand breaks, to a novel anti-cancer therapeutic target
A Suraweera, PHG Duijf, C Jekimovs, K Schrobback, C Liu, MN Adams, ...
Cancers 13 (4), 830, 2021
32021
Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
A Suraweera, A Duff, MN Adams, C Jekimovs, PHG Duijf, C Liu, ...
British Journal of Cancer 124 (9), 1612, 2021
2021
216P COMMD1 in non-small cell lung cancer: A novel DNA repair protein as a therapeutic target and diagnostic biomarker
A Suraweera, P Duijf, M Tang, C Jekimovs, K Schrobback, C Liu, ...
Journal of Thoracic Oncology 16 (4), S813, 2021
2021
P1. 03-05 COMMD4 in Lung Cancer: Towards a New Therapeutic Target and Diagnostic Biomarker
A Suraweera, M Adams, C Jekimovs, D Richard, K O'Byrne
Journal of Thoracic Oncology 14 (10), S419, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8